FERNANDO SCAGLIA to Double-Blind Method
This is a "connection" page, showing publications FERNANDO SCAGLIA has written about Double-Blind Method.
Connection Strength
0.071
-
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial. Neurology. 2023 07 18; 101(3):e238-e252.
Score: 0.040
-
Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trial. Neurology. 2020 02 18; 94(7):e687-e698.
Score: 0.031